Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers
- 1 October 2004
- journal article
- basic science
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (15) , 2009-2017
- https://doi.org/10.1097/00002030-200410210-00005
Abstract
Background: Antiretroviral drugs (ARV) as prophylaxis to prevent mother-to-child transmission of HIV results in decreased haematological parameters during and shortly after exposure, with recent data suggesting a more prolonged inhibition of haematopoiesis until at least 18 months. Design: Data on 156 HIV-infected and 1533 uninfected children in the European Collaborative Study followed from birth until at least 8 years of age. Methods: Smoothers and splines were used to elucidate patterns over age; linear mixed effects allowed for repeated measurements. Covariates included the child's HIV-1 infection status, prematurity, gender, race, drug withdrawal symptoms at birth and ARV exposure; effects on neutrophil count were quantified in regression analyses using z-scores (SD from mean) of neutrophil counts obtained after modelling untransformed values using the LMS method. For HIV-infected children, progression to AIDS and ARV therapy were also included. Results: After approximately 4 months of age, neutrophil counts were consistently and substantially lower in HIV-infected children than in uninfected children; in both groups, black children had significantly lower counts than white children across the whole age range. In uninfected children, male gender and ARV exposure were associated with reduced neutrophil count until at least 8 years of age. In HIV-infected children, advanced disease and ARV treatment were significantly associated with neutrophil count. Conclusion: A considerably longer effect of exposure to ARV was shown in uninfected children than previously thought and significant associations were shown between race and gender and neutrophil count, as previously observed for lymphocyte counts. The clinical relevance of these reduced levels of neutrophils requires further investigation.Keywords
This publication has 20 references indexed in Scilit:
- Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.Annals of the New York Academy of Sciences, 2006
- Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infantsAIDS, 2003
- Are There Gender and Race Differences in Cellular Immunity Patterns Over Age in Infected and Uninfected Children Born to HIV-Infected Women?JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Safety of Antiretroviral Prophylaxis of Perinatal Transmission for HIV-Infected Pregnant Women and Their InfantsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1JAMA, 2001
- HIV-infected pregnant women and vertical transmission in Europe since 1986AIDS, 2001
- Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus–infected pregnant womenAmerican Journal of Obstetrics and Gynecology, 2001
- Toxic Effects of Zidovudine in Asymptomatic Human Immunodeficiency Virus-Infected Individuals With CD4+ Cell Counts of 0.50×109/L or LessArchives of internal medicine (1960), 1992
- Smoothing reference centile curves: The lms method and penalized likelihoodStatistics in Medicine, 1992
- 3′‐Azido‐3′‐deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cellsBritish Journal of Haematology, 1988